Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells.

H Lu; Y Yang; E Gad; CA Wenner; A Chang; ER Larson; Y Dang; M Martzen; LJ Standish; ML Disis

doi:10.1158/1078-0432.ccr-10-1763

Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells.

H Lu, Y Yang, E Gad, CA Wenner, A Chang, ER Larson, Y Dang, M Martzen, LJ Standish, ML Disis

School of Biological Sciences

Research output: Contribution to journal › Article (Academic Journal) › peer-review

138 Citations (Scopus)

Original language	English
Journal	Clinical Cancer Research
DOIs	https://doi.org/10.1158/1078-0432.ccr-10-1763
Publication status	Published - Jan 2011

Access to Document

10.1158/1078-0432.ccr-10-1763

Handle.net

Persistent link

Cite this

@article{8094a39021d645fab7107cfb0ad4d890,

title = "Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells.",

author = "H Lu and Y Yang and E Gad and CA Wenner and A Chang and ER Larson and Y Dang and M Martzen and LJ Standish and ML Disis",

year = "2011",

month = jan,

doi = "10.1158/1078-0432.ccr-10-1763",

language = "English",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

}

TY - JOUR

T1 - Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells.

AU - Lu, H

AU - Yang, Y

AU - Gad, E

AU - Wenner, CA

AU - Chang, A

AU - Larson, ER

AU - Dang, Y

AU - Martzen, M

AU - Standish, LJ

AU - Disis, ML

PY - 2011/1

Y1 - 2011/1

UR - http://europepmc.org/abstract/med/21068144

U2 - 10.1158/1078-0432.ccr-10-1763

DO - 10.1158/1078-0432.ccr-10-1763

M3 - Article (Academic Journal)

C2 - 21068144

SN - 1078-0432

JO - Clinical Cancer Research

JF - Clinical Cancer Research

ER -

Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells.

Access to Document

Handle.net

Other files and links

Cite this